Navigation Links
Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
Date:5/27/2009

- Oral presentation on Sandostatin(R) LAR Depot Phase III data shows significant antitumor benefit in patients with advanced neuroendocrine tumors of the midgut

- Early data show that at eight weeks of treatment, Afinitor(R) stabilized or reduced tumor size in 61% of patients with advanced liver cancer

- New data reveal postmenopausal women with breast cancer taking Femara(R) experience better cognitive function than those taking tamoxifen

- Phase II data show potential of Glivec(R) in treating patients with advanced KIT-mutated melanoma; other Novartis data on advanced melanoma also presented

EAST HANOVER, N.J., May 28 /PRNewswire/ -- Novartis announced today that data on more than 15 compounds in its robust oncology portfolio will be included at the 2009 American Society of Clinical Oncology (ASCO) annual meeting. These studies provide new research on multiple tumor types and rare cancers.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/novartis/36143/

"Our strong presence at ASCO showcases our continued progress in developing innovative therapies for patients with cancer through our comprehensive discovery and development program," said David Epstein, President and CEO, Novartis Oncology, Novartis Molecular Diagnostics. "We look forward to continuing to explore novel ways to help patients in need of new treatments."

Sandostatin LAR in metastatic neuroendocrine midgut tumors

Data from the PROMID study (abstract #4508)* show Sandostatin(R) LAR Depot (octreotide acetate for injectable suspension) demonstrated a significant antitumor effect in patients with metastatic neuroendocrine tumors (NET) of the midgut(1).

Sandostatin LAR, when compared to placebo, more than doubled time without tumor growth (15.6 m
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
2. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
3. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
4. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
5. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
6. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
7. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
8. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
9. Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Dont Get Their Families Vaccinated
10. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
11. Video: Answer to Curing a Failing Heart May Exist in Bodys Own Do-It-Yourself Repair Kit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...wire-FirstCall/ -- Cornerstone Therapeutics Inc. (...y focused on acquiring, developing and commerciali...atory and related markets, today reported that it ...ug Administration ("FDA") alleging that its Decons...yrilamine Maleate 16 mg) and Deconsal DM chewable ...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- The Department of Health...ers of priority groups that did not have previous ... are being held statewide on Nov. 20-22. Friday,s ...turday, Nov. 21, will be 8 a.m. to 2 p.m. On Sunda...o 8 p.m. ,, Individuals in the recommended tar...
(Date:11/20/2009)...wswire/ -- ,, Reportlinker.com announces that ...atalogue. ,, India Medical Equipment Market An...eportlinker.com/p0164658/India-Medical-Equipment-M...ce=prnewswire&utm_medium=pr&utm_campaign=p...l Equipment Market Analysis and Forecasts to 2015 ...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 1PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 2PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 3Biologists educators recognize excellence in evolution education 10645 1Biologists educators recognize excellence in evolution education 10645 2Federal Judge Rejects Tobacco Companies Effort to Block Key Provisions of New Tobacco Regulation Law 60808 1Federal Judge Rejects Tobacco Companies Effort to Block Key Provisions of New Tobacco Regulation Law 60808 2
...linical Potential of Peregrine,s,Unique Selective ...vastin(R) in Animal Cancer Models, TUSTIN, Calif.,...e Pharmaceuticals, Inc. , a clinical stage,biophar...antibodies,for the treatment of cancer and hepatit...m multiple studies presented at the recent,Centenn...
...007 /PRNewswire-FirstCall/,Micromet, Inc. today an...arch collaboration with MedImmune, Inc. for the de...noembryonal antigen (CEA),a validated tumor- asso...an carcinomas. Preclinical data recently presented...ation for Cancer,Research (AACR) showed that CEA-B...
Other Medicine Technology:Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7Micromet Achieves Milestone in BiTE Research Collaboration with,MedImmune 2Micromet Achieves Milestone in BiTE Research Collaboration with,MedImmune 3Micromet Achieves Milestone in BiTE Research Collaboration with,MedImmune 4
(Date:11/20/2009).../PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals C...reholders will be held on Monday, December 21, 200...val of two special resolutions. The first special ... all or substantially all of the assets of NUCRYST...sset purchase agreement dated November 10, 2009 am...
(Date:11/20/2009)...0 Rates of infection by ...ate October, but the pandemic flu virus continues ...ups, including the elderly, according to a new rep... ), the world,s leading provider of diagnostic tes... recent Quest Diagnostics Health Trends(TM) Report...
(Date:11/20/2009)...swire-USNewswire/ -- The following is a statement ... Health Care Association: ,, "The Nevada Health...e Majority Leader Harry Reid for his leadership in...f protecting every Nevada seniors, ongoing access ...trength and viability of our state,s vital frontli...
(Date:11/20/2009)..., 2009Emergency medical service (EMS) providers in...diac arrests each year. Only 5 to 10 percent of p...ter quality cardiopulmonary resuscitation (CPR) pr...ted with better patient outcome. The Resuscitatio...l research network to study prehospital treatments...
(Date:11/20/2009)...is expected to continue, CDC says, , , ...the United States are seeing declines in H1N1 swin...day, and while the disease remains widespread in 4...last week. , "We are beginning to see some decl... there is still a lot of influenza everywhere," Dr...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3
...M) Applications Show Individuals How Much They Wil...d Improve Their Healthcare , , ANN ARBOR, Mich., ...eir healthcare and its cost, employers and health ... , , To address this challenge, HealthEquity has ...
...acob Hacker First to Detail How to Structure " Hea... Plan and Private Plans , , WASHINGTON, April 8 ... nation,s health care system, Jacob Hacker was t...Hacker, who is the co-director of the U.C. Berkele...
... provide state employees with health and wellness ...ess (NYSE Amex: FIT ) today announced a partners...nister a comprehensive health management program f... the program at a press conference this week, maki...
... April 8 While celebrity DUIs dominate the headli...ve solutions to educate the world about the danger...Michael Aguilar announced today that former Nation...es. , , "No one is above the law including celeb...
...on-smoking New Yorkers have elevated levels of cot...tly exposed to toxic second-hand smoke in concentr...Cotinine, a by-product of nicotine breakdown, is n...and Tobacco Research , shows that 57% of adult New...
...uice and chalky fiber supplements, just sit down a... published online in The FASEB Journal ( http://...ered a new way to make it a lot easier to go to th... bowels to pass waste, and the specific receptor n...
Other Medicine News:Health News:HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions 2Health News:HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions 3Health News:New Report Details How to Create a Public Health Insurance Option as Part of Nation's Health Reforms 2Health News:New Report Details How to Create a Public Health Insurance Option as Part of Nation's Health Reforms 3Health News:HealthFitness Announces New Employee Health Partnership With State of Nebraska 2Health News:Innocorp, ltd. Hires Former MADD National President 2Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 2Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 3Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 4Health News:Prune juice not necessary: New research should make bowel movements easier 2
...Drug Screen Tests are available in 14 configuratio...Designed using Microgenics Antibody Technology, th...point of care immunoassay targeted to detect MDMA ...cross-reactivity to any isomer of methamphetamine ...
...ite test! QuickScreen™ multi-panel dip cards...our choice of any conceivable combination of 9 dif...r total flexibility for your drug testing program....-in timer tells you when to read the results. Our ...
Insure
...tely 500,000 people die each year of colon cancer ...mprovements (high contrast berium enema, colonosco...e in the success rate of curative treatment for co... past two decades. The chances of successful treat...
Medicine Products: